PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), a Company dedicated to orphan oncology products and specialty products, today announces the reinforcement of its development team with the appointment of Louis Kayitalire, MD, as Head of Research and Development.
